Literature DB >> 29712771

IgG Immunocomplexes Sensitize Human Monocytes for Inflammatory Hyperactivity via Transcriptomic and Epigenetic Reprogramming in Rheumatoid Arthritis.

Qiao Zhong1,2,3, Fang-Yuan Gong1, Zheng Gong1, Sheng-Hao Hua1, Ke-Qin Zeng1,4, Xiao-Ming Gao5,6,7.   

Abstract

Prevalence of circulating immunocomplexes (ICs) strongly correlates with rheumatoid arthritis (RA) in humans. Deposits of IgG-ICs are abundant in affected joints of patients, yet molecular mechanisms for the pathogenic roles of such ICs are not fully understood. In this study, we present evidence that IgG-ICs precipitated from RA sera sensitized human monocytes for a long-lasting inflammatory functional state, characterized by a strong TNF-α response to cellular proteins representing damage-associated molecular patterns and microbe-derived pathogen-associated molecular patterns. Importantly, plate-coated human IgG (a mimic of deposited IC without Ag restriction) exhibited a similarly robust ability of monocyte sensitization in vitro. The plate-coated human IgG-induced functional programming is accompanied by transcriptomic and epigenetic modification of various inflammatory cytokines and negative regulator genes. Moreover, macrophages freshly isolated from synovia of patients with RA, but not sera-negative arthropathy, displayed a signature gene expression profile highly similar to that of IC-sensitized human monocytes, indicative of historical priming events by IgG-ICs in vivo. Thus, the ability of IgG-ICs to drive sustainable functional sensitization/reprogramming of monocytes and macrophages toward inflammation may render them key players in the development of RA.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29712771     DOI: 10.4049/jimmunol.1701756

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis.

Authors:  Gemma D Banham; Colin Y C Lee; John R Ferdinand; Rebeccah J Matthews; Chenzhi Jing; Nicholas Smithers; Rab K Prinjha; Menna R Clatworthy
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 2.  Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Sachiko Hirose; Qingshun Lin; Mareki Ohtsuji; Hiroyuki Nishimura; J Sjef Verbeek
Journal:  Int Immunol       Date:  2019-10-16       Impact factor: 5.071

3.  M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction.

Authors:  Ya Li; Jie Li; Zheng Gong; Xiao-Hua Pan; Zi-Han Ma; Shu-Yan Ma; Hong-Min Wang; Hong-Liang Dong; Fang-Yuan Gong; Xiao-Ming Gao
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

Review 4.  Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.

Authors:  Jianlin Zuo; Jinshuo Tang; Meng Lu; Zhongsheng Zhou; Yang Li; Hao Tian; Enbo Liu; Baoying Gao; Te Liu; Pu Shao
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

5.  Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.

Authors:  Melissa Newling; Willianne Hoepel; Lisa T C Vogelpoel; Marieke H Heineke; Johan A van Burgsteden; Esther W M Taanman-Kueter; Dirk Eggink; Taco W Kuijpers; Tim Beaumont; Marjolein van Egmond; Martien L Kapsenberg; Dominique L P Baeten; Jeroen den Dunnen; Esther C de Jong
Journal:  Eur J Immunol       Date:  2018-09-14       Impact factor: 5.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.